1. Home
  2. BTOG vs ELUT Comparison

BTOG vs ELUT Comparison

Compare BTOG & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOG

Bit Origin Limited

HOLD

Current Price

$0.17

Market Cap

22.2M

Sector

Finance

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.52

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOG
ELUT
Founded
2018
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2M
23.3M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
BTOG
ELUT
Price
$0.17
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.0M
478.8K
Earning Date
03-30-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,495.00
$21,746,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.12
$0.50
52 Week High
$1.07
$4.31

Technical Indicators

Market Signals
Indicator
BTOG
ELUT
Relative Strength Index (RSI) 27.21 35.40
Support Level $0.21 $0.53
Resistance Level $0.23 $0.59
Average True Range (ATR) 0.02 0.06
MACD -0.00 -0.00
Stochastic Oscillator 4.74 14.73

Price Performance

Historical Comparison
BTOG
ELUT

About BTOG Bit Origin Limited

Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: